2015, Number 4
<< Back Next >>
Ann Hepatol 2015; 14 (4)
Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model
Torres-Villalobos G, Hamdan-Pérez N, Tovar AR, Ordaz-Nava G, Martínez-Benítez B, Torre-Villalvazo I, Morán-Ramos S, Díaz-Villaseñor A, Noriega LG, Hiriart M, Medina-Santillán R, Castillo-Hernandez MC, Méndez-Sánchez N, Uribe M, Torres N
Language: English
References: 21
Page: 540-546
PDF size: 162.27 Kb.
ABSTRACT
Background. The study of NAFLD in humans has several limitations. Using murine models helps to understand
disease pathogenesis. Aim. Evaluate the impact of 4 different diets in the production of NAFLD with
emphasis on a combined high-fat plus sustained high sucrose consumption.
Material and methods. Eight
week-old male Wistar rats were divided in four groups and fed for 90 days with the following diets: 1) Control
chow diet (C); 2) High-fat cholesterol diet (HFC) + 5% sucrose in drinking water. 3) High-fat cornstarch
diet (HFCO) + 5% sucrose in drinking water. 4) Chow diet + 20% sucrose in drinking water (HSD). Metabolic
changes, leptin levels, liver histology, hepatic and plasma lipid composition, fasting plasma glucose and insulin
and liver gene expression of FAS, SREBP-1 and PPAR-α were evaluated.
Results. The HFC diet had the
highest grade of steatosis (grade 2 of 3) and HSD showed also steatosis (grade 1). Liver weight TG and cholesterol
concentrations in liver were greater in the HFC diet. There were no increased levels of iron in
the liver. Rats in HFC gained significantly more weight (P ‹ 0.001). All experimental groups showed fasting
hyperglycemia. HFC had the highest glucose level (158.5 ± 7 mg/dL) (P ‹ 0.005). The HSD and the HFCO diets
developed also hyperglycemia. HSD had significantly higher fasting hyperinsulinemia. Serum leptin was
higher in the HFC diet (p = 0.001). In conclusion, the HFC diet with combination of high fat and high sucrose
is more effective in producing NAFLD compared with a high sucrose diet only.
REFERENCES
Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.
Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-23.
Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2300-08.
Anstee QM. Animal models in nonalcoholic steatohepatitis research: utility and clinical translation. Liver Int 2011; 31: 440-2.
Cobbold JF, Anstee QM, Goldin RD, Williams HR, Matthews HC, North BV, Absalom N, et al. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin Sci (Lond) 2009; 116: 403-13.
Romestaing C, Piquet MA, Bedu E, Rouleau V, Dautresme M, Hourmand-Ollivier I, Filippi C, et al. Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab (Lond) 2007; 4: 4.
Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 2013; 62(1): 62-9.
Larque C, Velasco M, Navarro-Tableros V, Duhne M, Aguirre J, Gutierrez-Reyes G, Moreno J, et al. Early endocrine and molecular changes in metabolic syndrome models. IUBMB Life 2011; 63: 831-9.
Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012; 32: 3-13.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001; 21: 89-104.
Aguilera AA, Diaz GH, Barcelata ML, Guerrero OA, Ros RM. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 2004; 15: 350-7.
El Hafidi M, Cuellar A, Ramirez J, Banos G. Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Delta9 and Delta5-desaturase activities. J Nutr Biochem 2001; 12: 396-403.
Oron-Herman M, Kamari Y, Grossman E, Yeger G, Peleg E, Sabtay Z, Shamiss A, et al. Metabolic syndrome: comparison of the two commonly used animal models. Am J Hypertens 2008; 21: 1018-22.
Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jarvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42: 320-30.
Varela-Rey M, Embade N, Ariz U, Lu SC, Mato JM, Martinez- Chantar ML. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol 2009; 41: 969-76.
Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008; 118: 829-38.
Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander- Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008; 295(5): G987-G995.